{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:56:16Z","timestamp":1792670176967,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"vor","delay-in-days":5374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1093\/annonc\/mdi116","type":"journal-article","created":{"date-parts":[[2005,2,3]],"date-time":"2005-02-03T01:12:51Z","timestamp":1107393171000},"page":"549-557","source":"Crossref","is-referenced-by-count":150,"title":["A randomised comparison between 6 months of bolus fluorouracil\/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer"],"prefix":"10.1016","volume":"16","author":[{"given":"I.","family":"Chau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Iveson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hickish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lofts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Jodrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Oates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdi116_bb0010","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0959-8049(02)00061-8","article-title":"Follow-up of patients with colorectal cancer. Numbers needed to test and treat","volume":"38","author":"Kievit","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdi116_bb0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0305-7372(02)00047-6","article-title":"Adjuvant therapy in colon cancer: current status and future directions","volume":"28","author":"Chau","year":"2002","journal-title":"Cancer Treat Rev"},{"key":"10.1093\/annonc\/mdi116_bb0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1200\/JCO.1998.16.1.301","article-title":"Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer","volume":"16","author":"Meta-analysis Group In Cancer","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi116_bb0025","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/sj.bjc.6600995","article-title":"Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer","volume":"88","author":"Saini","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdi116_bb0030","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1093\/annonc\/mdi116_bb0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2307\/2344317","article-title":"Asymptotically efficient invariant procedures","volume":"135","author":"Peto","year":"1972","journal-title":"J R Stat Soc A"},{"key":"10.1093\/annonc\/mdi116_bb0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"29","author":"Cox","year":"1972","journal-title":"J R Stat Soc A"},{"key":"10.1093\/annonc\/mdi116_bb0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.1998.16.1.295","article-title":"Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer","volume":"16","author":"O'Connell","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi116_bb0050","first-page":"256a","article-title":"Fluorouracil, leucovorin and levamisole adjuvant therapy for colon cancer: five year final report of Int-0089","volume":"17","author":"Haller","year":"1998","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/mdi116_bb0055","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1200\/JCO.2003.10.065","article-title":"Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial","volume":"21","author":"Andre","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi116_bb0060","first-page":"240a","article-title":"Phase III randomized trial of bolus 5-FU\/leucovorin\/levamisole versus 5-FU continuous infusion\/levamisole as adjuvant therapy for high risk colon cancer (SWOG 9415\/INT-0153)","volume":"19","author":"Poplin","year":"2000","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/mdi116_bb0065","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJM198506063122301","article-title":"Prolongation of the disease-free interval in surgically treated rectal carcinoma","volume":"312","author":"Gastrointestinal Tumor Study Group","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdi116_bb0070","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199103143241101","article-title":"Effective surgical adjuvant therapy for high-risk rectal carcinoma","volume":"324","author":"Krook","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdi116_bb0075","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1200\/JCO.2002.07.132","article-title":"Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control\u2014final report of Intergroup 0114","volume":"20","author":"Tepper","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi116_bb0080","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jnci\/92.5.388","article-title":"Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02","volume":"92","author":"Wolmark","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdi116_bb0085","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM199408253310803","article-title":"Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery","volume":"331","author":"O'Connell","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdi116_bb0090","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1200\/JCO.20.6.1491","article-title":"Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer","volume":"20","author":"Sloan","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi116_bb0095","first-page":"939","volume":"345","author":"Lancet","year":"1995","journal-title":"International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer"},{"key":"10.1093\/annonc\/mdi116_bb0100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7326\/0003-4819-122-5-199503010-00001","article-title":"Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report","volume":"122","author":"Moertel","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdi116_bb0105","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1200\/JCO.1997.15.1.246","article-title":"Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer","volume":"15","author":"O'Connell","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi116_bb0110","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/annonc\/mdg359","article-title":"Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC)","volume":"14","author":"Di Costanzo","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdi116_bb0115","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(02)09836-7","article-title":"Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study","volume":"360","author":"Punt","year":"2002","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdi116_bb0120","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1054\/bjoc.2001.2117","article-title":"Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III","volume":"85","author":"Taal","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdi116_bb0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jnci\/80.1.30","article-title":"Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01","volume":"80","author":"Wolmark","year":"1988","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdi116_bb0130","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1200\/JCO.1993.11.10.1879","article-title":"The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03","volume":"11","author":"Wolmark","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi116_bb0135","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1016\/S1359-6349(03)91092-5","article-title":"Adjuvant chemotherapy in colorectal cancer: joint analyses of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group","volume":"1","author":"Glimelius","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdi116_bb0140","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0959-8049(02)00098-9","article-title":"Baseline quality of life predicts survival in patients with advanced colorectal cancer","volume":"38","author":"Maisey","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdi116_bb0145","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0959-8049(97)00049-X","article-title":"Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy","volume":"33","author":"Coates","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdi116_bb0150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1026442201191","article-title":"Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group","volume":"6","author":"Dancey","year":"1997","journal-title":"Qual Life Res"},{"key":"10.1093\/annonc\/mdi116_bb0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0169-5002(00)00179-3","article-title":"Quality of life in lung cancer patients: as an important prognostic factor","volume":"31","author":"Montazeri","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdi116_bb0160","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-2141.1997.222667.x","article-title":"Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma","volume":"97","author":"Wisloff","year":"1997","journal-title":"Nordic Myeloma Study Group. Br J Haematol"},{"key":"10.1093\/annonc\/mdi116_bb0165","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1200\/JCO.2004.08.154","article-title":"Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer\u2014pooled analysis from three multicenter, randomized, controlled trials using individual patient data","volume":"22","author":"Chau","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi116_bb0170","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"Andre","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdi116_bb0175","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1200\/JCO.2001.19.18.3801","article-title":"Mortality associated with irinotecan plus bolus fluorouracil\/leucovorin: summary findings of an independent panel","volume":"19","author":"Rothenberg","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi116_bb0180","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1200\/jco.2004.22.90140.3509","article-title":"Capecitabine (X) vs bolus 5-FU\/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT study): positive efficacy results of a phase III trial","volume":"22","author":"Cassidy","year":"2004","journal-title":"J Clin Oncol (Meeting Abstracts)"},{"key":"10.1093\/annonc\/mdi116_bb0185","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/annonc\/mdg500","article-title":"Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial","volume":"14","author":"Scheithauer","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdi116_bb0190","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1200\/JCO.2004.05.063","article-title":"American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer","volume":"22","author":"Benson","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi116_bb0195","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1200\/jco.2004.22.14_suppl.3501","article-title":"QUASAR: A randomized study of adjuvant chemotherapy (CT) vs observation including 3238 colorectal cancer patients","volume":"22","author":"Gray","year":"2004","journal-title":"J Clin Oncol (Meeting Abstracts)"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419477387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419477387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/16\/4\/549\/415062\/mdi116.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:39:06Z","timestamp":1734914346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419477387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0923753419477387"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdi116","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}